French National Study of Long-Term Health and Social Outcomes in Childhood Solid Tumor Survivors Diagnosed Before Age 19 and Before 2000
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2026-07-30
18000
Participants Needed
36
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a large national study in France to follow children who were treated for solid tumors before the year 2000 and under the age of 19. The study aims to improve understanding of the long-term health and social effects caused by cancer and its treatments, such as chemotherapy and radiotherapy. It focuses on estimating risks of adverse outcomes and finding ways to provide better follow-up care for survivors.
Participants medical records are reviewed to estimate the doses of radiation and chemotherapy received, and the study collects information from national registries and self-reported questionnaires about survivors health status, social conditions, and quality of life. The study also uses data from the French National Health Insurance system to track health expenses and care. The cohort will be followed for up to 20 years starting from 2011.
During the study, researchers monitor all health events over time since the diagnosis of childhood cancer. Data collected include vital status, causes of death, social factors, and health care use. The study has already identified increased risks of secondary cancers and other diseases linked to treatments. Participants provide consent and allow access to health data, and the research aims to help identify survivors at higher risk to improve their long-term care.
CONDITIONS
Brief Title
French Childhood Cancer Survivor Study
Research Team
F
Florent F. de Vathaire, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Institut National de la Santé Et de la Recherche Médicale, France
Lead Sponsor
Ligue contre le cancer, France
Collaborating Sponsor
Who Can Participate
Age: 0 - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosis of any type of solid childhood cancer in France
Diagnosis made before age 19
Diagnosis occurred between January 1, 1942, and December 31, 1999
Complete personal identification including first name, last name, date of birth, and place of birth
You will not qualify if you...
Diagnosis of leukemia
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Long-term Monitoring
Duration - Up to 20 years from 2011
Participants' health and social outcomes are tracked over time using medical records, national registries, and self-questionnaires to understand long-term effects of childhood cancer and its treatments.
Periodic data collection and questionnaires
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
French National Study of Long-Term Health and Social Outcomes in Childhood Solid Tumor Survivors Diagnosed Before Age 19 and Before 2000
Personalized Targeted Treatments for Childhood and Adolescent Cancers Using Tumor Genetic Profiles
Phase 1 and 2 Study of Novel Drug Combinations Including Paxalisib and Opdualag
Precision Medicine to Improve Treatment for Children and Young Adults with Cancer in Australia and New Zealand
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
[Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view].
François Pein, Laurence Iserin, Florent de Vathaire...
Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Markhaba Tukenova, Ibrahima Diallo, Mike Hawkins...